Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Nov 15, 2026; 18(11): 123558
Published online Nov 15, 2026. doi: 10.4251/wjgo.123558
Published online Nov 15, 2026. doi: 10.4251/wjgo.123558
Figure 2 MiR-31-5p modulates migration, proliferation, apoptosis, and related protein expression in HCT116 colorectal cancer cells.
A: Quantitative reverse transcription polymerase chain reaction analysis of miR-31-5p expression in HCT116 cells transfected with miR-31-5p mimic or inhibitor (n = 3); B: Wound healing assay showing the effect of miR-31-5p on HCT116 cell migration (scale bar = 200 μm) (n = 3); C: Colony formation assay showing the effect of miR-31-5p on HCT116 cell proliferation (n = 4); D: Flow cytometric analysis of the effect of miR-31-5p on HCT116 cell apoptosis (n = 3); E: Western blotting analysis of the effect of miR-31-5p on apoptosis-related protein expression in HCT116 cells (n = 3). aP < 0.05 vs control, bP < 0.01 vs control, eP < 0.01 vs miR-31-5p mimic (30 nM), hP < 0.01 vs miR-31-5p inhibitor (50 nM).
- Citation: Wu YL, Wang X, Du XX, Liu KL, Wang CF, Liu JC, Cao JM, Cui XL. Resveratrol suppresses ulcerative colitis and colitis-associated colorectal cancer via modulating the miR-31-5p/SATB2 axis. World J Gastrointest Oncol 2026; 18(11): 123558
- URL: https://www.wjgnet.com/1948-5204/full/v18/i11/123558.htm
- DOI: https://dx.doi.org/10.4251/wjgo.123558